Supplementation may help address nausea or deficiency, though excessive intake can cause adverse effects
GLP-1 Tracker: Injections Log App The GLP-1 Tracker app (also called Glapp) is a mobile tool specifically crafted to support users of GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound
This versatility makes them an excellent tool for functional medicine practitioners who look at the whole person
The dosage of these other agents may need to be reduced to lower the risk of low blood sugar levels
Youll also receive Nooms full program, GLP-1 Companion access, and support from a dedicated Care Team
Sources Healthline: Weight Loss is Often a Losing Battle NIH: Glucagon-like peptide 1 (GLP-1) Cleveland Clinic: GLP-1 Agonists NIH: Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes American Diabetes Association: GLP-1 Receptor in Pancreatic -Cells Regulates Glucagon Secretion in a Glucose-Dependent Bidirectional Manner NIH: GLP-1 suppresses glucagon secretion in human pancreatic alpha-cells by inhibition of P/Q-type Ca2+ channels NIH: Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function FDA: Concern Over Compounded GLP-1 Drugs FDA Label: OZEMPIC (Semaglutide Injection) Medication Guide FDA Label: WEGOVY (Semaglutide Injection) Medication Guide FDA Label: RYBELSUS (Oral Semaglutide) Medication Guide FDA Label: MOUNJARO (Tirzepatide Injection) Medication Guide FDA Label: ZEPBOUND (Tirzepatide Injection) Medication Guide Important Medical Information and Disclaimers Medical Disclaimer This information is for educational use only
